HMGCR and diabetes mellitus: Calcium channel blockers, HMG CoA reductase inhibitors, agents acting on the renin-angiotensin system, antithrombotic agents, diuretics, beta blocking agents, salicylic acid and its derivatives, drugs used in diabetes, and vasodilators used in cardiac diseases were linked to an increased LAS risk.